Therapies For SZ Flashcards
Atypical antipsychotic?
Clozapine - binds loosely to D2 receptors then rapidly dissociates
Conventional antipsychotic?
Chloropromazine - dopamine antagonist
Evaluate effectiveness of antipsychotics
Davis et al - 19% relapse rate on antipsychotics compared to 55% on a placebo
Evaluate appropriateness of antipsychotics
Hill - 30% of users taking convention for 7+ years develop tardive dyskinesia and in 75% of cases it’s irreversible
Psychological therapies
- CBT
2. Family intervention
Psychological therapies: CBT
Drury et al - benefits in terms of a reduction of positive symptoms and a 25-50% reduction in recovery time for patients given a combination of CBT and medication
CBT: stages
- ABC model used, rate intensity from 1-10
- Tests validity (empirical, logical, pragmatic, evaluating content)
- Develop alternatives and coping strategies, set goals
- Replace delusional thinking with rational beliefs
Evaluate effectiveness of CBT
Gould et al - statistically significant decrease in positive symptoms
Evaluate appropriateness of CBT
Kuipers et al - lower drop out rates and greater satisfaction when CBT was used in addition to antipsychotics
Psychological therapies: family intervention
Brown - SZs in families with high EE have more frequent relapses
NICE recommends that family intervention..
Be carried out for between 3 months and 1 year and include at least 10 planned sessions in conjunction with antipsychotics
NICE 2014 recommends that CBT…
Be used for 1st and subsequent acute episodes, delivered on a one to one basis over at least 16 planned sessions
Family intervention: stages
- Establish alliance and give information
- Discuss how they feel
- Learn constructive ways of communicating
- Learn practical coping skills and problem solving
- Trained to realise early signs of relapse
Evaluate effectiveness of family intervention
NCCMH - 26% relapse in FI compared to 50% in control standard-care
Evaluate appropriateness of family intervention
NCCMH - extra cost of FI is offset by a reduction in costs of hospitalisation due to lower relapse rates (26% v 50%)